Glycerophosphate does not interact with components of parenteral nutrition

Pharmacology

Volumn 88, Issue 1-2, 2011, Pages 114-120

  Topp, Heinrich ^a   Hochfeld, Olena ^a   Bark, Staffan ^b   Grossmann, Matthias ^c   Joukhadar, Christian ^d,e,f   Westphal, Martin ^a   Straatsma, Harald ^a   Rothenburger, Markus ^a  

^a Fresenius Kabi Deutschland GmbH   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c PAREXEL INTERNATIONAL   (United States)

^d JandP Medical Research Ltd   (Austria)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Glycerophosphate; Pharmacokinetic profile; Phosphorus; Total parenteral nutrition

Indexed keywords

GLYCEROPHOSPHATE; GLYCOPHOS; KABIVEN; PHOSPHATE; UNCLASSIFIED DRUG;

ADULT; ADVERSE OUTCOME; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BODY WEIGHT; CONSTIPATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; EMULSION; FEMALE; HEADACHE; HEMATOMA; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME TO MAXIMUM PLASMA CONCENTRATION; TOTAL PARENTERAL NUTRITION;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG COMPOUNDING; DRUG INTERACTIONS; FEMALE; GLYCEROPHOSPHATES; HUMANS; MALE; PARENTERAL NUTRITION; PARENTERAL NUTRITION, TOTAL; PHOSPHATES; PHOSPHOLIPIDS; THERAPEUTIC EQUIVALENCY; TIME FACTORS; YOUNG ADULT;

EID: 80051941303     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000330066     Document Type: Article

References (14)

1. Razzaque MS: Phosphate toxicity: New insights into an old problem. Clin Sci (Lond) 2011; 120: 91-97.
2. Amanzadeh J, Reilly RF Jr: Hypophosphatemia: An evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol 2006; 2: 136-148. (Pubitemid 43355193)
3. Martínez MJ, Martínez MA, Montero M, Campelo E, Castro I, Inaraja MT: Hypophosphatemia in postoperative patients with total parenteral nutrition: Influence of nutritional support teams. Nutr Hosp 2006; 21: 657-660. (Pubitemid 46089923)
4. SmPC for Kabiven-peripheral, dated April 2010, http://www.imb.ie/images/ uploaded/swedocuments/LicenseSPC-PA0566-003-001-07092010103909.pdf (available online on May 13, 2011).
5. Costello I, Powell C, Williams AF: Sodium glycerophosphate in the treatment of neonatal hypophosphataemia. Arch Dis Child Fetal Neonatal Ed 1995; 73:F44-F45.
6. Belfanti S, Contardi A, Ercoli A: Researches on the phosphatases: On the mechanism of the inactivating action of sodium oxalate and of phosphates on the 'alkaline' phosphatases of animal tissue. Biochem J 1935; 29: 1491-1507.
7. Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products -General Considerations: Http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/ucm070124.pdf (available online on May 13, 2011).
8. CPMP/EWP/QWP/1401/98; The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use: Http://www.ema.europa.eu/docs/ en-GB/document-library/Scientific-guide line/2009/09/WC500003519.pdf (available online on May 13, 2011).
9. Topp H, Hochfeld O, Bark S, Grossmann M, Joukhadar C, Westphal M, Straatsma H, Rothenburger M: Glycerophosphate is interchangeable with inorganic phosphate in terms of safety and serum pharmacokinetics. Pharmacology DOI: 10.1159/000331341.
10. Jubiz W, Canterbury JM, Reiss E, Tyler FH: Circadian rhythm in serum parathyroid hormone concentration in human subjects: Correlation with serum calcium, phosphate, albumin, and growth hormone levels. Clin Invest 1972; 51: 2040-2046.
11. Taylor DJ, Coppack SW, Cadoux-Hudson TA, Kemp GJ, Radda GK, Frayn KN, Ng LL: Effect of insulin on intracellular pH and phosphate metabolism in human skeletal muscle in vivo. Clin Sci (Lond) 1991; 81: 123-128.
12. Nilsson E: An open study with sodium glycerophosphate -to document safety and metabolism of sodium glycerophosphate in post-operative patients requiring TPN. Kabi Pharmacia Scientific Report (1991) 9196531.
13. Schildt B, Symreng T, Ohlin SE: Addex Electrolyte in Total Parenteral Nutrition (TPN). Project/Product Report L366G3. Uppsala, Pharmacia Infusion AB, 1981.
14. Croner S, Larsson J, Schildt B, Symreng T: Severe anorexia nervosa treated with total parenteral nutrition. Clinical course and influence on clinical chemical analyses. Acta Paediatr Scand 1985; 74: 230-236. (Pubitemid 15137078)